In today’s recent session, 1.86 million shares of the Applied Dna Sciences Inc (NASDAQ:APDN) have been traded, and its beta is 0.36. Most recently the company’s share price was $0.30, and it changed around -$0.01 or -3.78% from the last close, which brings the market valuation of the company to $3.07M. APDN at last check was trading at a discount to its 52-week high of $22.80, offering almost -7500.0% off that amount. The share price’s 52-week low was $0.28, which indicates that the recent value has risen by an impressive 6.67% since then. We note from Applied Dna Sciences Inc’s average daily trading volume that its 10-day average is 3.84 million shares, with the 3-month average coming to 10.72 million.
Applied Dna Sciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended APDN as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Applied Dna Sciences Inc is expected to report earnings per share of -0.34 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Applied Dna Sciences Inc (NASDAQ:APDN) trade information
Instantly APDN has been showing red trend so far today with a performance of -3.78% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4221 on recent trading dayincreased the stock’s daily price by 28.93%. The company’s shares are currently down -97.59% year-to-date, but still down -20.61% over the last five days. On the other hand, Applied Dna Sciences Inc (NASDAQ:APDN) is -67.93% down in the 30-day period. We can see from the shorts that 0.85 million shares have been sold at a short interest cover period of 0.29 day(s).
The consensus price target as assigned by Wall Street analysts is $1.5, which translates to bulls needing to increase their stock price by 80.0% from its current value. Analyst projections state that APDN is forecast to be at a low of $1.5 and a high of $1.5.
Applied Dna Sciences Inc (APDN) estimates and forecasts
Applied Dna Sciences Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -92.27 percent over the past six months and at a 88.16% annual growth rate that is well above the industry average of 14.80%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 93.50% in revenue this quarter, and will report an increase of 82.20% in the next quarter. The year-over-year growth rate is expected to be -73.70%, down from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 900k in revenue for the current quarter. 2 analysts expect Applied Dna Sciences Inc to make 1.04M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 780k and 891k respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 15.40%. Forecasts for the next quarter put sales growth at 16.70%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 45.52%.
APDN Dividends
Applied Dna Sciences Inc’s next quarterly earnings report is expected to be released on 2024-Dec-05.
Applied Dna Sciences Inc (NASDAQ:APDN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.04% of Applied Dna Sciences Inc shares, and 11.86% of them are in the hands of institutional investors. The stock currently has a share float of 12.23%. Applied Dna Sciences Inc stock is held by 23.0 institutions, with MATHER GROUP, LLC. being the largest institutional investor. By 2024-06-30, it held 0.0803% of the shares, which is about 700.0 shares worth $287.0.
Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Jun 30, 2024. The former held 8.68 shares worth $2586.0, making up 0.08% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 3.63 shares worth around $1083.0, which represents about 0.04% of the total shares outstanding.
